Blood Advances | 2024
Donor types and outcomes of transplantation in myelofibrosis: A CIBMTR study.
Jain T, Estrada-Merly N, Queralt Salas M, Kim S, DeVos J, Chen M, Fang X, Kumar R, Andrade Campos M, Elmariah H, Agrawal V, Aljurf M, Ulrike Bacher V, Badar T, Badawy S, Ballen K, Beitinjaneh A, Bhatt V, Bredeson C, DeFilipp Z, Dholaria B, Farhadfar N, Farhan S, Gandhi A, Ganguly S, Gergis U, Grunwald M, Hamad N, Hamilton B, Inamoto Y, Iqbal M, Jamy O, Juckett M, Kharfan-Dabaja MA, Krem M, Lad D, Liesveld J, Al Malki M, Malone AK, Murthy H, Ortí G, Patel S, Pawarode A, Perales M, van der Poel M, Ringden O, Rizzieri D, Rovo A, Savani B, Savoie M, Seo S, Solh M, Ustun C, Verdonck L, Wingard J, Wirk B, Bejanyan N, Jones R, Nishihori T, Oran B, Nakamura R, Scott B, Saber W, Gupta V
PubMed
PMID: 38916866
Abstract
Related Articles
CIBMTR Study #: CK21-01
Dataset Files:
This dataset was collected by the Center for International Blood and Marrow Transplant Research (CIBMTR) which is supported primarily by the Public Health Service U24CA076518 from the National Cancer Institute; the National Heart, Lung, and Blood Institute; the National Institute of Allergy and Infectious Diseases; 75R60222C00011 from the Health Resources and Services Administration; N00014-23-1-2057 and N00014-24-1-2057 from the Office of Naval Research; NMDP; and the Medical College of Wisconsin. By downloading the dataset files below, you agree to the Terms and Conditions.
I agree to the Terms and Conditions; Download Dataset
I agree to the Terms and Conditions; Download Data Dictionary